Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: THE INSTITUTE FOR CANCER RESEARCH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-01 to 2023-03-30
Current total value of award: $72517.5
Description: TO DE-OBLIGATE FUNDS FROM FY2018 EXPIRING LINES IN ACCORDANCE WITH NIH OALM COMMUNICATION 23-18  MODIFICATION TO INCORPORATE MTA FOR RENAL CELL CARCINOMA GENOME-WIDE ASSOCIATION STUDY: EXTRACTION OF GERMLINE DNA SAMPLES. POP 9/1/18 - 8/31/19.